文献速递小儿神经外科与脑积水

放射性核素分流管造影评估成人脑脊液分流管流量

Radionuclide shuntography for cerebrospinal fluid shunt flow evaluation in adults.
PubMed 文献 · J Neurosurg · 2023-09-08

该研究回顾性分析了2003年11月至2022年6月间142例成人脑积水患者的211次放射性核素分流管造影(RS),评估其对分流管功能障碍的诊断效用及并发症。RS检测分流管功能障碍的敏感度为92.3%、特异度为96.2%,显示功能障碍的研究后续翻修率显著高于通畅者(86.6% vs 2.9%,p<0.0001),且本队列无归因于RS的并发症或感染。作者结论认为RS是分流管功能障碍评估中有用且安全的工具。

要点

  • RS检测分流管功能障碍的敏感度为92.3%、特异度为96.2%。
  • RS显示功能障碍者后续翻修率86.6%,显著高于通畅者的2.9%(p<0.0001)。
  • 本队列无归因于RS的并发症或感染,作者认为RS有用且安全。

核心结论

  • 作者结论认为,放射性核素分流管造影是分流管功能障碍评估中有用且安全的工具。

研究设计与样本

  • 回顾性综述2003年11月至2022年6月间所有RS研究,纳入年龄≥18岁的分流管脑积水患者,排除因评估Ommaya储液囊而行RS者。
  • 共纳入142例患者的211次RS操作,操作时平均年龄55.6±20.9岁(均值±标准差)。
  • 脑积水病因以正常压力脑积水最常见(37.0%),其次为先天性畸形(26.1%)和特发性颅内高压(15.6%)。
  • 分类变量采用卡方检验,敏感度/特异度分析采用标准2×2列联表方法。

主要发现

  • 207次研究(98.1%)成功完成放射性核素注射。
  • 成功注射的研究中,确认分流管通畅者占63.8%,显示功能障碍者占27.1%,流速异常缓慢者占9.2%。
  • RS显示分流管功能障碍的研究后续行翻修的比例为86.6%,高于显示通畅的研究的2.9%(p<0.0001)。
  • RS检测分流管功能障碍的总体敏感度为92.3%,特异度为96.2%。
  • 中位随访时间为29个月,其中151例随访≥6个月。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Radionuclide shuntography (RS) performed using 99mTc-DTPA injected into the reservoir of CSF shunts enables evaluation of CSF flow for suspected shunt malfunctions. The goal of this study was to report the authors' institutional experience with RS and evaluate its utility and associated complications. METHODS: The authors retrospectively reviewed all RS studies performed between November 2003 and June 2022. Patients with shunted hydrocephalus who were ≥ 18 years of age were included. Patients undergoing RS for evaluation of Ommaya reservoirs were excluded. Demographics, hydrocephalus etiology, presenting symptoms, study results, subsequent management, complications, and intraoperative diagnoses were recorded. Chi-square tests were reported for categorical variables and standard 2 × 2 contingency methods were used for sensitivity/specificity analysis. RESULTS: The authors identified 211 RS procedures performed in 142 patients. The mean age at procedure was 55.6 ± 20.9 years (mean ± SD). Normal pressure hydrocephalus was the most common hydrocephalus etiology (37.0%), followed by congenital malformations (26.1%) and idiopathic intracranial hypertension (15.6%). Successful radionuclide injection was achieved in 207 studies (98.1%). Shunt patency was confirmed in 63.8% of successful injections, whereas malfunction was demonstrated in 27.1% and abnormally slow flow was seen in 9.2%. RS studies demonstrating shunt malfunction were more likely to result in subsequent revisions than were studies showing patency (86.6% vs 2.9%; p < 0.0001). The overall sensitivity and specificity of RS for detecting shunt malfunction was 92.3% and 96.2%, respectively. The median follow-up time was 29 months, with 151 cases having ≥ 6 months of follow-up. There were no complications or infections attributable to RS in this cohort. CONCLUSIONS: RS is a useful and safe tool in the workup of shunt malfunction.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Nandoliya KR, Klein JP, Alwakeal A, et al. Radionuclide shuntography for cerebrospinal fluid shunt flow evaluation in adults. J Neurosurg. 2023. PMID: 37725052. doi:10.3171/2023.7.JNS23455

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。